| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | GSK-1904529A | GDSC1000 | pan-cancer | AAC | 0.02 | 0.6 |
| mRNA | Irinotecan | FIMM | pan-cancer | AAC | 0.062 | 0.6 |
| mRNA | AZD6482 | CTRPv2 | pan-cancer | AAC | -0.024 | 0.6 |
| mRNA | Vorinostat | CTRPv2 | pan-cancer | AAC | -0.022 | 0.6 |
| mRNA | MS-275 | CTRPv2 | pan-cancer | AAC | -0.021 | 0.6 |
| mRNA | QW-BI-011 | CTRPv2 | pan-cancer | AAC | -0.044 | 0.6 |
| mRNA | Erlotinib | GDSC1000 | pan-cancer | AAC | -0.027 | 0.6 |
| mRNA | CAY10576 | CTRPv2 | pan-cancer | AAC | 0.026 | 0.6 |
| mRNA | serdemetan:SCH-529074 (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.022 | 0.6 |
| mRNA | Rapamycin | gCSI | pan-cancer | AAC | 0.035 | 0.6 |